The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

As per The Business Research Company’s Clinical Trial Supplies Global Market Report 2023, The global clinical trial supplies market is expected to grow from $2.31 billion in 2022 to $2.52 billion in 2023 at a compound annual growth rate (CAGR) of 9.2%. The clinical trial supplies market is expected to reach $3.43 billion in 2027 at a CAGR of 8%.

What was the major driver in the clinical trial supplies market?
The increasing number of registered clinical trials is expected to propel the growth of the clinical trial supplies market going forward. Clinical trials are research studies conducted with human participants to evaluate the safety and effectiveness of new medical treatments, interventions, or diagnostic procedures. Clinical trial supplies, including pharmaceuticals, medical devices, and other essential materials, are crucial for conducting successful clinical trials, supporting the research process, ensuring accurate data collection, and maintaining the patients’ safety. For instance, in May 2023, according to ClinicalTrials.gov, a part of the National Institutes of Health (NIH), a US-based government agency responsible for conducting and supporting medical research, in 2023, around 437,533 clinical trials were registered, compared to 399,499 registered studies in 2022 in all 50 states of the United States and across 221 countries. Therefore, the increasing number of registered clinical trials is driving the growth of the clinical trial supplies market.

View More On The Clinical Trial Supplies Market Report 2023 – https://www.thebusinessresearchcompany.com/report/clinical-trial-supplies-global-market-report

What was the key trend in the clinical trial supplies market?
Advancements in real-world evidence platforms are a key trend gaining popularity in the clinical trial supplies market. Major companies operating in the clinical trial supplies market are adopting innovative technologies to transform healthcare decision-making, drug development, and patient care by leveraging real-world data to generate evidence-based insights and sustain their position in the market. For instance, in April 2023, Komodo Health, a US-based healthcare technology company that specializes in services related to patient recruitment, site selection, and real-time data monitoring for clinical trials, launched MapEnhance, a network of specialty data partners integrated into a real-world evidence (RWE) technology platform. MapEnhance empowers customers with a comprehensive and detailed real-world perspective on clinical events and patient populations, enabling unprecedented insight. MapEnhance includes precision molecular diagnostics for various therapeutic areas, high-volume standard laboratory diagnostics for earlier disease visibility, and electronic medical records capturing clinical encounters. It also offers inpatient and outpatient facility chargemasters for detailed cost and utilization insights across different hospital settings.

Which was the largest region in the clinical trial supplies market?
North America was the largest region in the clinical trial supplies market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in clinical trial supplies report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the clinical trial supplies market prominent players?
Major players in the clinical trial supplies market are Thermo Fisher Scientific Inc., IQVIA, Eurofins Scientific SE, Parexel International Corporation, ICON PLC, Catalent Inc., Intertek Group PLC, Recipharm AB, World Courier, Almac Group Ltd., Piramal Pharma Solutions, Clinigen Group PLC, Movianto GmbH, Marken Limited, PCI Pharma Services, Rubicon Research Private Limited, Bionical Ltd., Durbin PLC, SIRO Clinpharm Pvt. Ltd., Biocair International Ltd., Ancillare LP., Myonex, Klifo A/S, Alium Medical Limited, ADAllen Pharma, and Sharp Services LLC.

Key clinical trial supplies market segments
The global clinical trial supplies market is segmented –
1) By Services: Logistics And Distribution, Storage And Retention, Supply Chain Management, Packaging, Labeling, And Blinding, Manufacturing, Comparator Sourcing
2) By Clinical Phases: Phase I, Phase II, Phase III, Phase IV
3) By Therapeutic Use: Oncology, Central Nervous System (CNS), Cardiovascular, Infectious Disease, Metabolic Disorders, Other Therapeutic Uses
4) By End User: Pharmaceutical And Biotech companies, Contract Research Organization (CRO), Medical Device Companies

Request A Sample Of The Global Clinical Trial Supplies Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12133&type=smp

The Clinical Trial Supplies Global Market Report 2023  provides a comprehensive overview on the clinical trial supplies market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies

View More Related Reports –
Clinical Oncology Next Generation Sequencing Global Market Report 2023
Clinical Decision Support Systems Global Market Report 2023
Clinical Microbiology Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model